Life sciences company Azenta (NASDAQ:AZTA) reported Q3 CY2025 results topping the market’s revenue expectations , with sales up 5.5% year on year to $159.2 million. Its non-GAAP profit of $0.19 per ...

Azenta (AZTA) just released quarterly results that showed meaningful gains in both revenue and profitability compared to last year. The company also set expectations for continued organic growth into ...

Azenta (NASDAQ:AZTA) will release its quarterly earnings report on Friday, 2025-11-21. Here's a brief overview for investors ahead of the announcement. Analysts anticipate Azenta to report an earnings ...

Life sciences company Azenta (NASDAQ:AZTA) will be reporting results this Friday before the bell. Here’s what to look for. Azenta missed analysts’ revenue expectations by 3.8% last quarter, reporting ...

BURLINGTON, Mass. - On Friday, Azenta, Inc. (NASDAQ:AZTA) reported fourth-quarter results that exceeded analyst expectations, with improved margins and solid revenue growth. The life sciences ...

Azenta, Inc. (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable ...

Azenta Inc. (NASDAQ:AZTA) reported its fiscal fourth quarter and full year 2025 results on November 21, 2025, highlighting solid revenue growth, significant margin expansion, and a strong cash ...

The company anticipates organic revenue growth in the range of 3% to 5% for fiscal 2026. Multiomics is expected to deliver low single-digit growth, while Sample Management Solutions is expected to ...

Shares of life sciences company Azenta (NASDAQ:AZTA) jumped 4.2% in the afternoon session after a report revealed that the White House plans to pitch a two-year extension of Obamacare subsidies. The ...

Greetings, and welcome to the Azenta Q4 2025 Financial Results. [Operator Instructions] As a reminder, this conference is being recorded Friday, November 21, 2025. I will now turn the conference over ...

Raymond James also highlighted expectations for Azenta’s path to margins exceeding 20%, supporting its decision to raise the price target while maintaining its Outperform rating. In other recent news, ...

Shares of Azenta advanced after the company swung to a profit and posted sales growth in the latest quarter. Shares rose 12% to $33.51 in late morning trading on Friday, but are still down 33% this ...